Rbc Life Sciences 8 K Form (Page 2 of 5) in pdf

Rbc Life Sciences 8 K Form Page 2

Item 2.02 Results of Operations and Financial Condition.

On November 8, 2012, RBC Life Sciences, Inc. (the “Company”) issued a press release announcing its financial results for the

quarter ended September 30, 2012. A copy of the press release is being furnished as Exhibit 99.1 to this Form 8-K.

In accordance with General Instruction B.2 of Form 8-K, this information, including the exhibit related hereto, is furnished

pursuant to Item 2.02 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of

1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing of the Company under

the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such

filing.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits

Exhibit No.

Description

99.1

Press release dated November 8, 2012 announcing financial results for the quarter ended September 30, 2012.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on

its behalf by the undersigned hereunto duly authorized.

Date: November 8, 2012

RBC Life Sciences, Inc.

By: /s/ Richard S. Jablonski

Name: Richard S. Jablonski

Title: Vice President - Finance and Chief Financial Officer

Rbc Life Sciences 8 K Form Page 2